Tandem Diabetes Care
TNDM
TNDM
265 hedge funds and large institutions have $2.98B invested in Tandem Diabetes Care in 2019 Q1 according to their latest regulatory filings, with 83 funds opening new positions, 80 increasing their positions, 81 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
33% more funds holding
Funds holding: 200 → 265 (+65)
1% less repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 81
1.94% less ownership
Funds ownership: 83.13% → 81.19% (-1.9%)
Holders
265
Holding in Top 10
12
Calls
$84.5M
Puts
$54M
Top Buyers
| 1 | +$91.2M | |
| 2 | +$32M | |
| 3 | +$30.7M | |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$26.6M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$19.4M |
Top Sellers
| 1 | -$68.8M | |
| 2 | -$40.5M | |
| 3 | -$35.6M | |
| 4 |
FAM
Fred Alger Management
New York
|
-$34.4M |
| 5 |
DM
Deerfield Management
New York
|
-$32.9M |